Measuring brain responses to visual stimuli in people with hearing loss

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to explore the use of Visual Evoked Potential (VEP) testing to assess brain responses in individuals with hearing loss. Participants will undergo two appointments where they will complete visual tests, VEP testing, auditory assessments, and cognitive evaluations. The study focuses on measuring the P300 wave, a specific brain response to new visual stimuli, to determine its relevance in improving treatments for hearing loss. The testing will be conducted at Dartmouth Hitchcock Medical Center, utilizing non-invasive electrodes to monitor brain activity.

Why it matters

Who can join: the full rules

Inclusion

* Subjects will be recruited from the Otolaryngology/Audiology clinic at DHMC with the goal of enrolling subjects with a variety of degrees of hearing loss and central auditory processing dysfunction.
* Age \> 18 y/o.
* Current and new patients receiving care in the DHMC Otolaryngology clinic or from the employees of Dartmouth College, DHMC, and the community, will be included as allowed under COVID guidelines.

Exclusion

* Patients with known brain pathology (e.g., CNS tumors, CVA diagnosis, etc…) will be excluded.
* Patients with severe neurological or neuropsychological disorders will be excluded.
* Patients with known seizure history will be excluded.
* Patients with known blindness will be excluded.
* The following special populations will not be included:
* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers)
* Prisoners

Where it's running

• Dartmouth Hitchcock Medical Center
  Lebanon, New Hampshire, United States Recruiting

Study contacts

• Principal investigator: James E Saunders, MD — Department of Surgery, Otolaryngology section, Dartmouth Hitchcock Medical Center
• Study coordinator: Michaela M Geffert, BS
• Email: Michaela.M.Geffert@hitchcock.org
• Phone: 6036502054

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers in Congenital Hearing Loss: Alpha-Tectorin, IL-10, and Thiol-Disulfide Balance in Children

  This observational study tests whether levels of alpha-tectorin, IL-10, and thiol-disulfide balance differ in children with congenital sensorineural hearing loss (with cochlear implants or hearing aids) compared with healthy children.

  Recruiting Harran University · Sanliurfa · NCT07860580

• Anatomy-based fitting for single-sided deaf CI users

  This study tests whether anatomy-based fitting changes how well adults with single-sided deafness use a cochlear implant to understand speech in noise and to enjoy music.

  Recruiting University Hospital, Antwerp · Antwerp · NCT07703800

• Long-term outcomes of MED-EL SONATA 2 Cochlear Implants in real life

  This study looks at long-term results from people who received a SONATA 2 cochlear implant to see how well it works in everyday life.

  Recruiting MED-EL Elektromedizinische Geräte GmbH · Madrid and 1 other locations · NCT07697911

• Anatomy-Based Fitting for People with a Cochlear Implant and Hearing Aid

  This study tests whether an anatomy-based frequency distribution works better than the default one for adults with a cochlear implant and a contralateral hearing aid.

  Recruiting at 2 sites Universitair Ziekenhuis Brussel · Antwerp and 1 other locations · NCT07691853

• WhatsApp AI support vs paper support for first-time hearing aid users

  This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.

  Recruiting at 2 sites University of Pretoria · Pretoria, Province and 1 other locations · NCT07690670

• Biomarkers linked to congenital CMV using newborn blood spots

  Researchers will test protein and RNA markers in dried blood spots from newborns to see if they can identify congenital CMV sequelae early.

  Recruiting at 2 sites Copenhagen University Hospital, Rigshospitalet · Copenhagen and 1 other locations · NCT07635368

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.